Trial Profile
Phase I trial of non-aqueous glucagon (CSI-Glucagon) for the prevention of hypoglycaemia in paediatric patients with congenital hyperinsulinism
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Adverse reactions
- Sponsors XERIS Pharmaceuticals
- 16 Apr 2015 New trial record
- 14 Apr 2015 Xeris Pharmaceuticals has been awarded a Phase I-II Fast Track SBIR grant and has received the initial instalment for this trial, which will be conducted at two US children's hospitals, according to a media release.